The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

Journal of Experimental Medicine

Volumn 188, Issue 12, 1998, Pages 2199-2204

  Kalams, Spyros A ^a   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD9 ANTIGEN; HLA A ANTIGEN;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARENAVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HELPER CELL; HEPATITIS B VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INFECTION RESISTANCE; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIREMIA;

ANIMALS; ARENAVIRIDAE INFECTIONS; CLONAL ANERGY; HIV INFECTIONS; HUMANS; LYMPHOCYTE COOPERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS DISEASES;

EID: 0032418812     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.12.2199     Document Type: Note

References (11)

1. Murray, R.J., M.G. Kurilla, J.M. Brooks, W.A. Thomas, M. Rowe, E. Kieff, and A.B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176:157-168.
2. Khanna, R., S.R. Burrows, M.G. Kurilla, C.A. Jacob, I.S. Misko, T.B. Sculley, E. Kieff, and DJ. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-176.
3. UNAIDS/WHO Working Group on Global HIV/AIDS and STD Surveillance. 1998. HIV/AIDS: the global epidemic (1997). http://hivinsite.ucsf.edu/social/un/2098.371d.html# estimates
4. Sharara, A.I., C.M. Hunt, and J.D. Hamilton. 1996. Hepatitis C. Ann. Intern. Med. 125:658-668.
5. Yang, O.O., S.A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B.D. Walker, and R.P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70:5799-5806.
6. Yang, O.O., S.A. Kalams, A. Trocha, H. Cao, A. Luster, R.P. Johnson, and B.D. Walker. 1997. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
7. Guidotti, L.G., K. Ando, M.V. Hobbs, T. Ishikawa, L. Runkel, R.D. Schreiber, and F.V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:3764-3768.
8. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
9. Price, D.A., A.K. Sewell, T. Dong, R. Tan, P.J. Goulder, S.L. Rowland-Jones, and R.E. Phillips. 1998. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr. Biol. 8:355-358.
10. Wagner, L., O.O. Yang, E.A. Garcia-Zepeda, Y. Ge, S.A. Kalams, B.D. Walker, M.S. Pasternack, and A.D. Luster. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391:908-911.
11. McMichael, A.J., and C.A. O'Callaghan. 1998. A new look at T cells J. Exp. Med. 187:1367-1371.